Hypomagnesemia risk factors

Overview

The following patients have high risk of hypoglycemia development, critically ill patients, hospitalized patients, burned patients, head and neck cancer patients treated with cetuximab

Risk factors

The following patients have high risk of hypoglycemia development:

Critically ill patients
Hospitalized patients
Burned patients^[1]
Head and neck cancer patients treated with cetuximab^[2]

References

↑ Durán-Vega HC, Romero-Aviña FJ, Gutiérrez-Salgado JE, Silva-Díaz T, Ramos-Durón LE, Carrera-Gómez FJ (2004). “[Risk factors for development of hypomagnesemia in the burned patient]”. Gac Med Mex. 140 (6): 577–82. PMID 15633562.
↑ Enokida T, Suzuki S, Wakasugi T, Yamazaki T, Okano S, Tahara M (2016). “Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab”. Front Oncol. 6: 196. doi:10.3389/fonc.2016.00196. PMC 5021713. PMID 27683640.

[pmid15633562-1] Durán-Vega HC, Romero-Aviña FJ, Gutiérrez-Salgado JE, Silva-Díaz T, Ramos-Durón LE, Carrera-Gómez FJ (2004). “[Risk factors for development of hypomagnesemia in the burned patient]”. Gac Med Mex. 140 (6): 577–82. PMID 15633562.

[pmid27683640-2] Enokida T, Suzuki S, Wakasugi T, Yamazaki T, Okano S, Tahara M (2016). “Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab”. Front Oncol. 6: 196. doi:10.3389/fonc.2016.00196. PMC 5021713. PMID 27683640.

[1]

[2]